Biovail Appoints Lloyd Segal to Company's Board of Directors.TORONTO -- Biovail Corporation (NYSE NYSE See: New York Stock Exchange :BVF BVF Biovail Corporation (stock symbol) BVF Berufsverband der Frauenärzte eV (Muenchen, Germany) BVF Bearing Versus Frequency )(TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension :BVF) today announced that Canadian pharmaceutical industry veteran Lloyd M. Segal, Chief Executive Officer of Thallion Pharmaceuticals Inc. of Montreal, has been appointed to Biovail's Board of Directors. Mr. Segal's appointment is effective immediately. "We're delighted to welcome Lloyd Segal to Biovail's Board of Directors," said Dr. Douglas Squires, Interim Chairman of the Board and the Company's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "Mr. Segal's appointment provides pharmaceutical industry expertise upon which both the Board, and the Company's management team, can draw as Biovail moves through the next phase of its development." Mr. Segal served as President and CEO of Caprion Pharmaceuticals of Montreal from 1998 until its merger earlier this year with Ecopia BioSciences to form Thallion Pharmaceutials, a biotechnology company focused on the development of new treatments for underserved markets in the areas of oncology and infectious disease. He was previously a management consultant with McKinsey & Co., and President and CEO of Advanced Bioconcept Ltd., which was sold to NEN Nen, river, China Nen (nŭn) or Nonni (nôn`nē), river, 740 mi (1,191 km) long, rising in the Yilehuli (Ilkuri) Mts., N Heilongjiang prov. Life Sciences (now Perkin-Elmer) in 1998. Mr. Segal is currently a member of the Board of Directors at GBC GBC Game Boy Color GBC Global Business Coalition GBC Green Building Council GBC George Brown College GBC Great Basin College (Nevada) GBC General Binding Corporation GBC Greater Baltimore Committee GBC Goldey-Beacom College North American Growth Fund, Inc., one of Canada's leading growth-oriented mutual funds. He is also a member of the Brandeis University Science Advisory Council. Previously, Mr. Segal was a member of the Board of Directors of BIOTECanada, Canada's national biotechnology industry association. He has also served on the boards of both TSX and NASDAQ-listed public companies, and privately held companies in the health-care industry. Mr. Segal received his Masters Degree in Business Administration from Harvard Business School Harvard Business School, officially named the Harvard Business School: George F. Baker Foundation, and also known as HBS, is one of the graduate schools of Harvard University. in Cambridge, MA. He also holds a Bachelor of Arts degree in Politics from Brandeis University in Waltham, MA. About Biovail Corporation Biovail Corporation is a specialty pharmaceutical company, engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products utilizing advanced drug-delivery technologies. For more information about Biovail, visit the Company's Web site at www.biovail.com. For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to ir@biovail.com. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion